NEW YORK (GenomeWeb) – Researchers have used the CRISPR/Cas9 gene-editing tool in mice to disrupt a gene that causes glaucoma. As they also were able to target the gene in human eye cultures, the researchers said their study suggests CRISPR/Cas9 editing could work in the eye.